Nationwide Variation in Rates of Thyroidectomy Among US Medicare Beneficiaries

被引:24
|
作者
Francis, David O. [1 ]
Randolph, Gregory [2 ,3 ]
Davies, Louise [4 ,5 ,6 ]
机构
[1] Univ Wisconsin, Dept Surg, Wisconsin Surg Outcomes Res Grp, Div Otolaryngol, Madison, WI 53706 USA
[2] Massachusetts Eye & Ear Infirm, Div Thyroid & Parathyroid Endocrine Surg, Boston, MA USA
[3] Harvard Med Sch, Dept Otolaryngol, Boston, MA USA
[4] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT USA
[5] Geisel Sch Med Dartmouth, Sect Otolaryngol, White River Jct, VT USA
[6] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA
关键词
UNITED-STATES; SURGERY; TRENDS;
D O I
10.1001/jamaoto.2017.1746
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Research on variation in rates of procedures across otherwise similar geographic regions provides vital insight into practice patterns. It reveals the degree of consensus on how a particular condition is managed, shows areas where access to care may be inadequate, and other areas where the population may be receiving inappropriately high levels of care. OBJECTIVE To test the hypothesis that rates of thyroid surgery vary across US geographic regions DESIGN, SETTING, AND PARTICIPANTS A cross-sectional analysis of Medicare data for 15 888 beneficiaries aged 65 years or older from 2014 was carried out. MAIN OUTCOME AND MEASURES Overall and hospital referral region-specific thyroidectomy rate per 100 000 Medicare beneficiaries. RESULTS In 2014, 15 888 thyroidectomies were performed on Medicare beneficiaries in the United States (partial n = 7506, total n = 8382), representing a national average rate of 60 per 100 000 beneficiaries (median, 59 per 100 000 beneficiaries; IQR, 43-70 per 100 000). A 6.2-fold difference in thyroidectomy rates was observed across US regions (range, 22-139 per 100 000 Medicare beneficiaries). CONCLUSIONS AND RELEVANCE Thyroidectomy rates in the United States vary 6.2 fold, more than prostatectomy rates, which are usually held as the example of the procedure with the widest variation in the United States. This wide variation in thyroidectomy rates observed among Medicare beneficiaries suggests widely divergent local beliefs and practice patterns surrounding the management of thyroid nodules and cancer because rates appeared to be unrelated to health care availability, regional socioeconomic status, or surgeons per capita. A better understanding for the reasons underlying this variation is needed.
引用
收藏
页码:1122 / 1125
页数:4
相关论文
共 50 条
  • [41] Trends in Patch Testing by Health Care Providers Among US Medicare Beneficiaries
    Singh, Partik
    Liszewski, Walter
    DERMATITIS, 2021, 32 (06) : 406 - 412
  • [42] Adherence with Intravenous Zoledronic Acid and Ibandronate for Osteoporosis Among US Medicare Beneficiaries
    Curtis, Jeffrey R.
    Yun, Huifeng
    Matthews, Robert
    Saag, Kenneth G.
    Delzell, Elizabeth S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S430 - S430
  • [43] Kidney Stone Disease and Risk of Osteoporotic Fractures among US Medicare Beneficiaries
    Maalouf, Naim
    Oerline, Mary
    Hsi, Ryan
    Best, Sara
    Crivelli, Joseph
    Hollingsworth, John
    Shahinian, Vahakn
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 241 - 241
  • [44] Characterization of long COVID among US Medicare beneficiaries using claims data
    Lu, Yun
    Lindaas, Arnstein
    Izurieta, Hector S.
    Cozen, Myrna L.
    Menis, Mikhail
    Shi, Xiangyu
    Steele, Whitney
    Wernecke, Michael
    Chillarige, Yoganand
    Kelman, Jeffery A.
    Forshee, Richard A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 212 - 212
  • [45] Sleep disorders and the development of Alzheimer's disease among US Medicare beneficiaries
    Dun, Chen
    Walsh, Christi M.
    Chu, Nadia M.
    McAdams-DeMarco, Mara
    Hashim, Farah
    Makary, Martin A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (01) : 299 - 301
  • [46] Adherence with Intravenous Zoledronic Acid and Ibandronate for Osteoporosis among US Medicare Beneficiaries
    Curtis, Jeffrey R.
    Yun, Huifeng
    Matthews, Robert S.
    Saag, Kenneth G.
    Delzell, Elizabeth
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S154 - S154
  • [47] Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries
    Lu, Yun
    Lindaas, Arnstein
    Izurieta, Hector S.
    Cozen, Myrna
    Menis, Mikhail
    Shi, Xiangyu
    Steele, Whitney R.
    Wernecke, Michael
    Chillarige, Yoganand
    Kelman, Jeffrey A.
    Forshee, Richard A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (02)
  • [48] Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
    Sandhaus, Robert
    Strange, Charlie
    Stone, Glenda
    Runken, M. Chris
    Blanchette, Christopher M.
    Howden, Reuben
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2389 - 2397
  • [49] UTILIZATION AND COST OF DIABETIC MEDICATIONS AMONG US MEDICARE PART D BENEFICIARIES
    Zhao, J.
    Carlson, A. M.
    VALUE IN HEALTH, 2017, 20 (05) : A177 - A177
  • [50] Pneumoconiosis incidence and prevalence among US Medicare beneficiaries, 1999-2019
    Kurth, Laura
    Casey, Megan L.
    Mazurek, Jacek M.
    Blackley, David J.
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2023, 66 (10) : 831 - 841